Key Takeaways
- Best quarter in IGI's history: Highest-ever volumes, revenue, EBITDA and profits, with H1 revenue growing 27% and EBITDA 34%, well ahead of the 15%/20% guidance set in May.
- Lab-grown is the growth engine, natural is resilient: LGD loose certification grew 37% and jewelry certification 47%, while natural diamond certification grew 8% despite a soft natural market.
- Full-year guidance upgraded, no specific number given: Management expects H2 to deliver growth similar to H1, but repeatedly declined to pin down a revised percentage target when pressed.
- India margins dipped on deliberate investment: Standalone EBITDA margin fell 340 bps to 69.5% as the company spent on leadership, marketing and commissions; consolidated margins expanded on operating leverage.
- What to watch next quarter: Whether the lab-grown supply ramp continues converting into certification volumes at the same pace, how natural diamond momentum holds through the festive season, and any color on when India margin investments start paying back.
Lab-Grown Diamond: Supply, Demand & IGI's Role
- Supply ramp is structural, not cyclical: Large Indian growers are adding reactors and doubling capacity over three years; management sees supply at its base, not its peak, and expects no slowdown in LGD business for coming quarters.
- Retail adoption broadening fast: In India, lab-grown chains are opening stores and established jewelers have launched LGD brands; in the US, more than 50% of all bridals are now lab-grown. LGD jewelry certification grew 47% in Q2 and 46% in H1, with consistency across quarters.
- New geographies opening: Markets for LGD jewelry are expanding into Europe, Latin America and Australia, a trend management expects to continue.
- LGD revenue stable quarter-on-quarter: Consolidated LGD revenue was ₹211.1 crore in Q2, essentially flat vs ₹209.5 crore in Q1, as scale-up from grower capacity additions flows into laboratories for certification.
- First-time diamond buyers as a future natural-diamond pipeline: For many families, a lab-grown diamond is the very first diamond they buy; as household income rises they buy more pieces, bigger stones, and over coming years will move to natural diamonds.
- IGI's certificate as the market's backbone: Management argues the IGI certificate is what makes a lab-grown diamond a diamond and protects natural diamond value, positioning the company as the independent standard a market of this size needs.
Printer: "It is the IGI certificate that makes the lab-grown diamond a diamond, and it is the same certificate that also protects the value of a natural diamond."
Natural Diamond Business
- Growth despite a soft natural market: Natural diamond certification grew 8% YoY in Q2 and 5% sequentially, with H1 up 7% after a slow start to the year; traction is building.
- Natural jewelry certification lagged: Grew only 3% in Q2, as high and volatile gold prices made buyers of natural diamond jewelry take longer to decide.
- Momentum expected to hold: Management expects the natural diamond momentum to continue into the next two quarters.
Financial Performance & Margins
- Consolidated margin expansion: Q2 EBITDA margin reached 61.4%, up from 60.4% in Q1 and 60.1% in FY25-26, as operating leverage translated EBITDA growth faster than revenue growth.
- India standalone margin compression: EBITDA margin fell 340 bps YoY (69.5% vs 72.8%), driven by investments in employee leadership, additional marketing and commission expenses. H1 PAT margins also dropped 340 bps on the same investments.
- ARP drivers: India standalone ARP rose 7% driven by increased mix of LGD stones (up 6%); base business ARP grew 2% on higher LGD loose stone mix. Consolidated ARP rose 4% YoY, split evenly between AGL consolidation and base business LGD mix shift.
- ARP sequential decline is seasonal: ARP fell 12% QoQ because LGD loose stones mix was 4% lower and jewelry mix was up ~3-4%, a normal seasonal pattern entering the festive Q2/Q3 period.
- Overseas subsidiaries profitable: Overseas certification revenues grew 31% without AGL, and the business is increasingly profitable.
- Operating leverage trend expected to persist: Management expects EBITDA growth to continue outpacing revenue growth.
Competitive Position & Moats
- First-mover advantage in LGD certification: IGI was the first to certify lab-grown diamonds, establishing trust and acceptance over 50 years.
- The 4Cs as an enduring commercial standard: Management argues the 4Cs establish the commercial value at which goods trade across the value chain and will not go away.
- Stance on lab-grown as a diamond: IGI is the only laboratory in the world to acknowledge lab-grown as a diamond, refusing to "lesser" it to something mundane; management sees this as a defining differentiator.
Printer: "We are the only laboratory in the world to acknowledge it as a diamond because both are exactly the same and natural diamond is earth-mined, laboratory diamond is man-made but both are diamonds... We will not lesser the diamond, like lab-grown, to something which is mundane."
Strategic Initiatives
- Geographic expansion underway: Started operations in Italy this year, venturing into Saudi Arabia, and set up a company in Botswana in September.
- AGL integration and global push: AGL has been part of IGI Group since January; colored stone capabilities are being built in other laboratories using AGL methods, and AGL itself is ready for a growth charter and expansion into key gemstone markets.
- AI in laboratory operations: AI-based work allocations and scheduling are now in use, enabling the same team to grade more stones more efficiently and faster while keeping grading standards constant.
- Brand investment scaling: Brand research volume for IGI is up 66% since March 2026; the company is reaching 2 crore unique audience every quarter consistently and has clocked 15 crore+ views on campaigns year-to-date. Capabilities are being built for regional content and strategy within India and across key global geographies.
- Capital allocation priorities unchanged: Invest in capacities, geographies, and technology, selective bolt-on acquisitions, and return surplus cash; the Board reviews with each set of results.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Full-year revenue and EBITDA growth | Outperform initial guidance of 15% revenue / 20% EBITDA growth; deliver H2 growth similar to H1 (revenue ~27%, EBITDA ~34%) | FY27 full year |
| Natural diamond momentum | Momentum to continue | Next 2 quarters |
| Lab-grown business momentum | No slowdown anticipated; tailwind from grower capacity addition | Coming quarters |
| Operating leverage trend | EBITDA growth faster than revenue growth to continue | Ongoing |
| Capital allocation sequence | Invest for growth first, then M&A, then dividends | Ongoing |
| AGL global expansion | Extend AGL services to other parts of the globe; territories under evaluation but not disclosed | No timeline given |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Revenue from operations (consolidated) | ₹398 cr, +31% YoY |
| Certification revenue (consolidated) | ₹387.5 cr, +32% YoY |
| EBITDA (consolidated) | ₹244.5 cr, +39% YoY |
| EBITDA margin (consolidated) | 61.4%, +340 bps YoY |
| PAT (consolidated) | ₹185.8 cr, +43% YoY |
| PAT margin (consolidated) | 46.7%, +400 bps YoY |
| Reports issued | 0.43 cr, +26% YoY |
| Average realization per report (consolidated) | ₹891, +4% YoY; AGL contributed 2%, base business ARP grew 2% on higher LGD mix |
| Lab-grown loose certification revenue growth | 37% YoY |
| Lab-grown jewelry certification revenue growth | 47% YoY |
| Natural loose certification revenue growth | 8% YoY |
| Natural jewelry certification revenue growth | 3% YoY |
| Gemstones and other certification revenue growth | 331% YoY |
| India standalone revenue from operations | ₹305.6 cr, +27% YoY |
| India standalone EBITDA margin | 69.5%, down 340 bps YoY; investments in leadership, marketing, and commissions |
| Overseas subsidiaries certification revenue growth (ex-AGL) | 31% YoY |
| Cash and bank balance (group) | ₹1,074.9 cr as of quarter close |
| Operating cash flow (H1 FY27) | ₹415.7 cr, 89% of EBITDA and 118% of PAT |
| Full-year FY27 revenue growth outlook | Outperforming, similar to H1 delivery of 27% growth; prior guidance of 15% revised upward |
| Full-year FY27 EBITDA growth outlook | Outperforming, similar to H1 delivery of 34% growth; prior guidance of 20% revised upward |